410 related articles for article (PubMed ID: 22027727)
21. Current drug-eluting stents in complex patients and lesions.
Elezi S; Dibra A; Schömig A; Kastrati A
Minerva Cardioangiol; 2006 Feb; 54(1):5-22. PubMed ID: 16467738
[TBL] [Abstract][Full Text] [Related]
22. Repeat in-stent restenosis of drug-eluting stents in a bifurcation treated successfully with kissing drug eluting balloons.
Abergel E; Beyar R; Roguin A
Cardiovasc Revasc Med; 2013; 14(2):106-8. PubMed ID: 23195308
[TBL] [Abstract][Full Text] [Related]
23. Two-year follow-up of the Genous™ endothelial progenitor cell capturing stent versus the Taxus Liberté stent in patients with de novo coronary artery lesions with a high-risk of restenosis: a randomized, single-center, pilot study.
Beijk MA; Klomp M; van Geloven N; Koch KT; Henriques JP; Baan J; Vis MM; Tijssen JG; Piek JJ; de Winter RJ
Catheter Cardiovasc Interv; 2011 Aug; 78(2):189-95. PubMed ID: 21542109
[TBL] [Abstract][Full Text] [Related]
24. Atheroma and coronary bifurcations: before and after stenting.
Yazdani SK; Nakano M; Otsuka F; Kolodgie FD; Virmani R
EuroIntervention; 2010 Dec; 6 Suppl J():J24-30. PubMed ID: 21930487
[TBL] [Abstract][Full Text] [Related]
25. NEVO™: a new generation of sirolimus-eluting coronary stent.
Falotico R; Parker T; Grishaber R; Price S; Cohen SA; Rogers C
EuroIntervention; 2009 Dec; 5 Suppl F():F88-93. PubMed ID: 22100684
[No Abstract] [Full Text] [Related]
26. Stent choice in primary percutaneous coronary intervention: drug-eluting stents or bare metal stents?
Valgimigli M; Airoldi F; Zimarino M
J Cardiovasc Med (Hagerstown); 2009 Oct; 10 Suppl 1():S17-26. PubMed ID: 19851216
[TBL] [Abstract][Full Text] [Related]
27. The PICCOLETO study and beyond.
Cortese B
EuroIntervention; 2011 May; 7 Suppl K():K53-6. PubMed ID: 22027728
[TBL] [Abstract][Full Text] [Related]
28. A multicenter, randomized study to test immunosuppressive therapy with oral prednisone for the prevention of restenosis after percutaneous coronary interventions: cortisone plus BMS or DES versus BMS alone to eliminate restenosis (CEREA-DES) - study design and rationale.
Ribichini F; Tomai F; De Luca G; Boccuzzi G; Presbitero P; Pesarini G; Ferrero V; Ghini AS; Pastori F; De Luca L; Zavalloni D; Soregaroli D; Garbo R; Franchi E; Marino P; Minelli M; Vassanelli C
J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):192-9. PubMed ID: 19377384
[TBL] [Abstract][Full Text] [Related]
29. Is there a preferable DES in diabetic patients? A critical appraisal of the evidence.
Byrne RA; Kastrati A
Catheter Cardiovasc Interv; 2008 Dec; 72(7):944-9. PubMed ID: 19021280
[TBL] [Abstract][Full Text] [Related]
30. Percutaneous coronary intervention in small coronary vessels: from balloon angioplasty to drug eluting stent era.
Rathore S; Kaul U
Indian Heart J; 2011; 63(3):228-33. PubMed ID: 22734340
[TBL] [Abstract][Full Text] [Related]
31. Formulation of nanoparticle-eluting stents by a cationic electrodeposition coating technology: efficient nano-drug delivery via bioabsorbable polymeric nanoparticle-eluting stents in porcine coronary arteries.
Nakano K; Egashira K; Masuda S; Funakoshi K; Zhao G; Kimura S; Matoba T; Sueishi K; Endo Y; Kawashima Y; Hara K; Tsujimoto H; Tominaga R; Sunagawa K
JACC Cardiovasc Interv; 2009 Apr; 2(4):277-83. PubMed ID: 19463437
[TBL] [Abstract][Full Text] [Related]
32. Drug-coated balloon treatment of coronary artery disease: a position paper of the Italian Society of Interventional Cardiology.
Cortese B; Berti S; Biondi-Zoccai G; Colombo A; Limbruno U; Bedogni F; Cremonesi A; Silva PL; Sgueglia GA;
Catheter Cardiovasc Interv; 2014 Feb; 83(3):427-35. PubMed ID: 23934956
[TBL] [Abstract][Full Text] [Related]
33. Drug-eluting stents: clinical experiences and perspectives.
Grube E; Gerckens U; Buellesfeld L
Minerva Cardioangiol; 2002 Oct; 50(5):469-73. PubMed ID: 12384629
[TBL] [Abstract][Full Text] [Related]
34. Oral sirolimus after bare metal stent implantation: a glimpse to the future.
Mieres J
Catheter Cardiovasc Interv; 2011 Jan; 77(1):158-9. PubMed ID: 20931667
[No Abstract] [Full Text] [Related]
35. Rapamycin analogs for stent-based local drug delivery. Everolimus- and tacrolimus-eluting stents.
Grube E; Buellesfeld L
Herz; 2004 Mar; 29(2):162-6. PubMed ID: 15054588
[TBL] [Abstract][Full Text] [Related]
36. Comparison of sirolimus-eluting stent, paclitaxel-eluting stent, and bare metal stent in the treatment of long coronary lesions.
Kim YH; Park SW; Lee CW; Hong MK; Gwon HC; Jang Y; Lee MM; Koo BK; Oh DJ; Seung KB; Tahk SJ; Yoon J; Park SJ
Catheter Cardiovasc Interv; 2006 Feb; 67(2):181-7. PubMed ID: 16400663
[TBL] [Abstract][Full Text] [Related]
37. Drug-coated balloons for the treatment of in-stent restenosis in diabetic patients: A review of currently available scientific data.
Minacapelli A; Piraino D; Buccheri D; Cortese B
Catheter Cardiovasc Interv; 2018 Jul; 92(1):E20-E27. PubMed ID: 28544361
[TBL] [Abstract][Full Text] [Related]
38. Long-term clinical outcomes after sirolimus-eluting stent implantation for treatment of restenosis within bare-metal versus drug-eluting stents.
Whan Lee C; Kim SH; Suh J; Park DW; Lee SH; Kim YH; Hong MK; Kim JJ; Park SW; Park SJ
Catheter Cardiovasc Interv; 2008 Apr; 71(5):594-8. PubMed ID: 18311841
[TBL] [Abstract][Full Text] [Related]
39. Rationale and study design of the OISTER trial: optical coherence tomography evaluation of stent struts re-endothelialization in patients with non-ST-elevation acute coronary syndromes--a comparison of the intrEpide tRapidil eluting stent vs. taxus drug-eluting stent implantation.
Iaccarino D; Politi L; Rossi R; Sgura F; Monopoli D; Modena MG; Sangiorgi GM
J Cardiovasc Med (Hagerstown); 2010 Jul; 11(7):536-43. PubMed ID: 20090547
[TBL] [Abstract][Full Text] [Related]
40. Paclitaxel-eluting balloon: from bench to bed.
De Labriolle A; Pakala R; Bonello L; Lemesle G; Scheinowitz M; Waksman R
Catheter Cardiovasc Interv; 2009 Apr; 73(5):643-52. PubMed ID: 19309715
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
